Portfolio (Quarterly)
Guide ↗
Opaleye Management Inc.
· CIK 0001595855| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | ASRT | ASSERTIO HOLDINGS INC | Healthcare | 285,000.0 | $2.6M | 0.34% | NEW | — | $9.07 | +157.7% |
| 42 | — | VENTYX BIOSCIENCES INC | — | 251,932.0 | $2.3M | 0.30% | NEW | — | $9.03 | — |
| 43 | — | OPUS GENETICS INC | — | 1,120,000.0 | $2.3M | 0.30% | +20K | +1.8% | $2.01 | — |
| 44 | — | SUTRO BIOPHARMA INC | — | 190,671.0 | $2.2M | 0.29% | NEW | — | $11.57 | — |
| 45 | CABA | CABALETTA BIO INC | Healthcare | 900,000.0 | $2.0M | 0.26% | +91K | +11.3% | $2.19 | +68.5% |
| 46 | ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | 1,400,906.0 | $1.9M | 0.25% | +1.1M | +342.6% | $1.35 | +174.8% |
| 47 | — | GENERATION BIO CO | — | 310,000.0 | $1.8M | 0.23% | NEW | — | $5.68 | — |
| 48 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 18,319.0 | $1.4M | 0.18% | NEW | — | $76.49 | -8.1% |
| 49 | ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | 75,000.0 | $1.2M | 0.16% | NEW | — | $15.77 | -12.3% |
| 50 | QTTB | Q32 BIO INC | Healthcare | 213,363.0 | $708K | 0.09% | NEW | — | $3.32 | +70.8% |
| 51 | AVIR | ATEA PHARMACEUTICALS INC | Healthcare | 179,815.0 | $642K | 0.09% | NEW | — | $3.57 | +18.8% |
| 52 | SLN | SILENCE THERAPEUTICS PLC | Healthcare | 78,926.0 | $480K | 0.06% | NEW | — | $6.08 | +2.6% |
| 53 | — | RAPT THERAPEUTICS INC | — | 150,000.0 | $213K | 0.03% | NEW | — | $1.42 | — |
| 54 | ADGM | ADAGIO MED HLDGS INC | Healthcare | 18,444.0 | $19K | 0.00% | -92K | -83.3% | $1.04 | -18.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%